MSALI: INFECTIONS. Terms ■Pathogens ■Host ■Colonization ■Reservoir ■Causative Agents ■Bacteria ■Aerobic ■Anaerobic ■Mode of Transmission ■Portal of Entry.

Slides:



Advertisements
Similar presentations
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Advertisements

MSALI: INFECTIONS.
Nursing Assistant Monthly Copyright © 2015 Cengage Learning. All rights reserved. CNAs are the first line of defense Common infections.
Common Communicable Diseases
Nursing Care of Clients with Upper Respiratory Disorders.
Lesson 3 Common Communicable Diseases When you have a cold, the best thing to do is rest, eat nutritious foods, and drink plenty of fluids such as water.
Infectious diseases Diseases resulting from the infectioninfection.
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.
Influenza Annual Training Health, healing and hope.
INFLUENZA (FLU) Management Presentation
1 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300 pt 400 pt 500 pt 100 pt 200 pt 300.
Influenza (The Flu).
Asepsis and Infection Control
Information source: Swine Flu What is Swine Influenza? Swine Influenza (swine flu) is a respiratory disease of pigs caused by type A influenza.
Common Communicable Diseases
MRSA Methicillin Resistant Staphylococcus Aureus
H ₁N₁ What you Need to Know Q & A Session Ozark’s Technical Community College Michelle Howard, RN, BSN.
Preventing Transmission of MRSA in the Hospital Setting Patricia A. Pearson RN, CIC Infection Prevention & Control Synergy / St. Joseph’s Hospital.
By: Sharee Windish, Haley Bradley & Jordan North
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
ESRD Network 6 5 Diamond Patient Safety Program
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
Health Care Personnel Influenza Vaccination [ORGANIZATION NAME] [ORGANIZATION LOGO]
Patient Care In Medical Imaging RAD 233 Abdulrahman Al Sayyari, PhD, MBA, &MS.c.
Influenza (Flu)
It’s safety and I know it!. The Chain of Infection.
Big Bad Bugs in the Dialysis Unit Douglas Shemin, MD Kidney Diseases and Hypertension Division, Rhode Island Hospital.
Standard and Expanded Precautions
You can lower your chances of catching a communicable disease by learning about the causes and symptoms of these diseases, and how to avoid them.
. Nosocomial Antibiotic Resistant Organisms Copyright © Texas Education Agency, All rights reserved.
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Connie Cavenaugh UAMS’ Infection Control Practitioner
Chapter 10 Infection Control.
Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.
MRSA 2006 Community Infection Control Nurses
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
SCIENTIFIC KNOWLEDGE BASE  ENTRY AND MULTIPLICATION OF ORGANISM RESULTS IN DISEASE  COLONIZATION OCCURS WHEN A MICROORGANISM INVADES THE HOST BUT DOES.
Infectious Respiratory Diseases
Q Fever By Karissa montano.
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
Definitions Infection control Infectious disease Pathogens.
CNA 2 OSBN Curriculum. layer/movie.php?movie= mrn.com/flv/78808ar_sec01_300k.flv&title =&detectflash=false.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
The Chain of Infection.
Swine Flu Dr Anil Ballani Consultant Physician Hinduja & Lilavati Hospital.
Methicillin-Resistant Staphylococcus Aureus (MRSA)
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Nosocomial infection Hospital acquired infections.
Standard Precautions And Infection Control For The CNA.
What is influenza? Influenza (also called "the flu") is a viral infection in the nose, throat and lungs. About 10% to 20% of Americans get the flu each.
Nosocomial infection Hospital acquired infections.
Infection Prevention Foundations For Long Term Care Jamie Moran, MSN, RN, CIC Quality Improvement Consultant May 12, 2016.
Copyright © 2008 Delmar Learning. All rights reserved. Unit 12 Infection.
Nosocomial Antibiotic Resistant Organisms
Anti-Microbial Resistance
MRSA Methicillin Resistant Staphylococcus Aureus
NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Hospital acquired infections
PHARMACOTHERAPY III PHCY 510
Nursing Care of Patients with Infections
CSI 101 Skills Lab 3 Universal Precautions and
HAI August 30, 2017.
HAI January 24, 2018.
HAI Sept. 25, 2017.
Nosocomial Infections(NCI)
Care of Patients with Infection
MRSA=Methicillin resistant Staphylococcus aureus
Spread of Cholera
Influenza Presentation for Health Care Workers
Presentation transcript:

MSALI: INFECTIONS

Terms ■Pathogens ■Host ■Colonization ■Reservoir ■Causative Agents ■Bacteria ■Aerobic ■Anaerobic ■Mode of Transmission ■Portal of Entry ■Portal of Exit ■Fungi ■Virus ■Protozoa ■Helminths ■Prions ■Human Body’s Defense Mechanisms ■Sepsis

Infection Control in Health-Care Agencies ■Community-acquired Infection ■Nosocomial Infection or Hospital – Acquired (HAI) ■Hand Hygiene

Nosocomial Infections ■Medicare implemented a policy on October 1, 2008 that penalizes hospitals if Medicare patients acquire any of 8 conditions during their inpatient stay ■3 of these conditions are infections: ■Catheter-Associated Urinary Tract Infection (UTI) ■Vascular Catheter-Associated Infection ■Surgical Site Infections, various

Nosocomial Infections ■Infection from Stay in Health-care Agency ■Risk Factors –Host’s Condition –Multiple Antibiotic Therapy –High-risk Units

Nosocomial Infections (cont’d) ■Common Pathogens –Escherichia coli (E. coli) –Staphylococcus aureus –Pseudomonas aeruginosa

Hand Hygiene ■Before and After –Patient Contact –Glove Use

Local vs. Systemic Infections ■Local ■Pain, redness, swelling, warmth at site ■Systemic ■Headache, malaise, fever, anorexia, aches. ■Can progress to hypotension, tachycardia, mental confusion

Gram Positive Bacteria

Medications to Treat Infectious Diseases ■Table 8.3 ■Nursing responsibilities: ■Note all patient allergies ■Obtain culture samples before initiating antibiotic treatment ■Monitor and report all side effects ■Observe for s/s of superinfections

Antibiotic Resistant Infections

Who Is At Risk? ■Severe and/or prolonged illness ■Persons with comorbidities – especially chronic renal disease, diabetes mellitus, peripheral vascular disease, skin lesions ■Previous exposure to antimicrobial agents ■Invasive procedures – such as dialysis, invasive devices, urinary cauterization, surgery ■Repeated contact with HC system ■Previous colonization of MDRO ■Advanced Age

MRSA ■Methicillin Resistant staphylococcus aureus ■- a bacteria ■Common sites : –Nares –Skin Colonized

Treatment ■I & D ■Contact ISO Precautions ■Clindamycin ■Tetracyclines ■Rifampin ■Linezolid ■Bactrim ■Mupirocin ointment for topical tx

Prevention ■Hand Hygiene ■Decolonization

Decolonization ■Mupirocin ointment for nares ■Use of daily chlorhexidine baths in ICU ■populations may decrease overall rates of ■bloodstream infections and MRSA ■acquisition, but effect on MRSA infections ■less clear

VRE ■Vancomycin-resistant Enterococci ■- a bacteria ■normally present in the human intestines and in the female genital tract and are often found in the environment.

What types of infections does VRE cause? ■It can cause infections of the urinary tract, the bloodstream, or of wounds associated with catheters or surgical procedures.

Who is at RISK? ■People who have been previously treated with the antibiotic vancomycin or other antibiotics for long periods of time. ■People who are hospitalized, particularly when they receive antibiotic treatment for long periods of time. ■People with weakened immune systems. ■People who have undergone surgical procedures. ■People with medical devices that stay in for some time such as urinary catheters or central intravenous (IV) catheters. ■People who are colonized with VRE.

Treatment ■People who are colonized do not usually need treatment. ■Most VRE infections can be treated successfully with antibiotics other than vancomycin. ■Laboratory testing of the VRE sample can determine which antibiotics will successfully treat the infection.

Clostridium difficile Infection ■A spore-forming, Gram-positive anaerobic bacillus ■The bacteria are found in the feces. ■Associated with ABX use.

S/S of Clostridium difficile infection? ■watery diarrhea (at least three bowel movements per day for two or more days) ■fever ■loss of appetite ■nausea ■abdominal pain/tenderness

The risk for disease increases in patients with: ■antibiotic exposure ■proton pump inhibitors ■gastrointestinal surgery/manipulation ■long length of stay in healthcare settings ■a serious underlying illness ■Immuno-compromising conditions ■advanced age

Treatment ■The infection can usually be treated with an appropriate course of antibiotics, ■including metronidazole, vancomycin, or recently approved fidaxomicin. ■Fecal Transplant

■Contact Isolation - Healthcare workers and visitors must use gloves and gowns on entry to a room of a patient with CDI. ■Emphasize compliance with the practice of hand hygiene.

Community Acquired Infections ■An infection acquired outside health care settings, such as in the home or in the community.

Communicable Diseases ■See Handout

Influenza ■Influenza viruses are spread from person to person primarily through large-particle respiratory droplet transmission (e.g., when an infected person coughs or sneezes near a susceptible person).

■The typical incubation period for influenza is 1—4 days (average: 2 days) ■Most healthy adults may be able to infect others beginning 1 day before symptoms develop and up to 5 to 7 days after becoming sick

S/S ■fever, myalgia, headache, malaise, nonproductive cough, sore throat, and rhinitis

Occurrence

Diagnostics ■Preferred respiratory samples for influenza testing include nasopharyngeal or nasal swab, and nasal wash or aspirate, depending on which type of test is used. ■Samples should be collected within the first 4 days of illness. ■Rapid influenza diagnostic tests provide results within 20 minutes or less; viral culture provides results in 3-10 days

Prevention – FLU Vaccination – for residents and employees ■Flu vaccines cause antibodies to develop in the body about two weeks after vaccination. These antibodies provide protection against infection with the viruses that are in the vaccine. ■The seasonal flu vaccine protects against the influenza viruses that research indicates will be most common during the upcoming season.

Treatments ■Three antiviral drugs recommended by the CDC & approved by the FDA: oseltamivir (brand name Tamiflu®), zanamivir (brand name Relenza®) and peramivir (brand name Rapivab®). Tamiflu® comes as a pill or liquid, and Relenza® is an inhaled powder. (Relenza should NOT be used in anyone with breathing problems, like asthma or COPD, for example.) Rapivab® is administered intravenously.

Complications ■Dehydration ■Pneumonia ■Change in Mental status

Nursing Diagnoses ■Fluid Volume, deficient ■Activity Intolerance ■Risk for Injury ■Impaired Comfort ■Risk for Ineffective Breathing